A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (>/= 12 to </= 17 Years of Age ) with Psoriasis.

Trial Profile

A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (>/= 12 to </= 17 Years of Age ) with Psoriasis.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Mar 2012

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 03 Mar 2012 Last checked against European Clinical Trials Database record.
    • 03 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 31 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top